Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.

被引：0
|
作者：
Bezalel, Nomi
Davidov, Yana
Likhter, Mariya
Ezra, Oranit Cohen
Inbar, Yael
Halpern, Naama
Ben Boursi
Beller, Tamar
Pery, Ron
Shmueli, Einat S.
Nachmany, Ido
Ben Ari, Ziv
Margalit, Ofer
机构：
[1] Sheba MC, Ramat Gan, Israel
[2] Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] Sheba Med Ctr, Oncol Inst, Ramat Gan, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16167
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
    Ha, Yeonjung
    Cheon, Jaekyung
    Hwang, Seong Gyu
    Chon, Hong Jae
    JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
  • [2] ANALYSIS OF FACTORS PREDICTING THE REAL-WORLD EFFICACY OF ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Ha, Chang Won
    Paik, Yong-Han
    Song, Byeong Geun
    HEPATOLOGY, 2024, 80
  • [3] Real-world experience of atezolizumab and bevacizumab for treatment of advanced hepatocellular carcinoma in a single tertiary center
    Raharjo, C. V.
    Joseph, R.
    Stratton, E.
    Levy, M.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 22 - 22
  • [4] Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
    Song, Byeong Geun
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Yong-Han
    GUT AND LIVER, 2024, 18 (04) : 709 - 718
  • [5] Atezolizumab and bevacizumab for advanced hepatocellular carcinoma: a single centre real world experience
    Tan, Pei Ying
    Hui, Samuel
    O'Neill, Paul
    Dev, Anouk
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 142 - 143
  • [6] Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data
    Shimose, Shigeo
    Sugimoto, Rie
    Hiraoka, Atsushi
    Tanaka, Masatoshi
    Iwamoto, Hideki
    Tanaka, Yuki
    Tada, Fujimasa
    Ohama, Hideko
    Niizeki, Takashi
    Shirono, Tomotake
    Moriyama, Etsuko
    Noda, Yu
    Kamachi, Naoki
    Nakano, Masahito
    Kuromatsu, Ryoko
    Koga, Hironori
    Kawaguchi, Takumi
    HEPATOLOGY RESEARCH, 2023, 53 (02) : 116 - 126
  • [7] Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
    Chon, Young Eun
    Kim, Dong Yun
    Kim, Mi Na
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Yong
    Ahn, Sang Hoon
    Ha, Yeonjung
    Lee, Joo Ho
    Lee, Kwan Sik
    Kang, Beodeul
    Kim, Jung Sun
    Chon, Hong Jae
    Kim, Do Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (03)
  • [8] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma
    Hwang, Sangyoun
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Kiyoun
    Lee, Yu Rim
    Park, Soo Young
    Jang, Byoung Kuk
    Chung, Woo Jin
    Tak, Won Young
    JOURNAL OF HEPATOLOGY, 2023, 78 : S588 - S588
  • [9] Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort
    de Castro, Tiago
    Welland, Sabrina
    Jochheim, Leonie
    Leyh, Cathrine
    Shmanko, Kateryna
    Finkelmeier, Fabian
    Jeliazkova, Petia
    Jefremow, Andre
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Roessler, Daniel
    Ben Khaled, Najib
    Enssle, Stefan
    Venerito, Marino
    Fruendt, Thorben W.
    Schultheiss, Michael
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Wirth, Thomas C.
    Marquardt, Jens U.
    Greil, Richard
    Fricke, Christina
    Guenther, Rainer
    Schmiderer, Andreas
    Bettinger, Dominik
    Wege, Henning
    Scheiner, Bernhard
    Mueller, Martina
    Strassburg, Christian P.
    Siebler, Juergen
    Ehmer, Ursula
    Waidmann, Oliver
    Weinmann, Arndt
    Pinter, Matthias
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [10] Real-world data: Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab in Veteran Health Administration
    Alkadimi, Munaf
    Lucero, Kana
    Boyle, Lauren Diaz
    Fierro, Maria Elena
    Franklin, Kathleen
    Nooruddin, Zohra
    Mader, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345